Literature DB >> 21376524

Bloodstream infection after elective liver transplantation is associated with increased mortality in patients with cirrhosis.

Constantine J Karvellas1, Mark McPhail2, Fred Pink3, Sonal Asthana4, Paolo Muiesan5, Nigel Heaton6, Georg Auzinger7, William Bernal8, Ian Eltringham9, Julia A Wendon10.   

Abstract

PURPOSE: This study aims to investigate what factors predict the development of postoperative bloodstream infection (BSI) in patients transplanted electively for chronic liver disease and compare outcomes in infected transplant recipients (BCLD) with noninfected patients (CLD).
METHODS: A retrospective cohort study of 218 patients who had elective liver transplantation (LT) between January 2003 and July 2005 and admitted to a specialist intensive care unit (ICU) was done.
RESULTS: Fifteen patients had BSI post-LT (BCLD, 29 isolates) while in the ICU, and 203 patients did not (CLD). Thirty-eight percent of isolates were gram negatives; 55%, gram positives; and 7%, fungemia. Median time to first BSI post-LT was 11 days (range, 3-16 days). On admission post-LT to the ICU, patients with BCLD had higher Acute Physiology and Chronic Health Evaluation II scores (23 vs 10, P < .001). While in the ICU, patients with BCLD had greater requirements for renal replacement therapy (73% vs 8%) and days on mechanical ventilation (17 vs 2 days) and longer median ICU stay (21 vs 3 days, P < .001 for all). One-year survival was worse in the BCLD group (40% vs 94%, P < .001). On multivariate analysis, Acute Physiology and Chronic Health Evaluation II score (odds ratio, 1.36) post-LT was independently associated with subsequent BSI. Bloodstream infection (hazards ratio, 8.7) was independently associated with mortality.
CONCLUSION: Bloodstream infection post-LT was associated with increased severity of illness on admission, greater requirements for organ support, and increased mortality.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21376524     DOI: 10.1016/j.jcrc.2010.12.018

Source DB:  PubMed          Journal:  J Crit Care        ISSN: 0883-9441            Impact factor:   3.425


  5 in total

Review 1.  A meta-analysis of complications following deceased donor liver transplant.

Authors:  Lisa M McElroy; Amna Daud; Ashley E Davis; Brittany Lapin; Talia Baker; Michael M Abecassis; Josh Levitsky; Jane L Holl; Daniela P Ladner
Journal:  Am J Surg       Date:  2014-07-18       Impact factor: 2.565

2.  The combination of MELD score and ICG liver testing predicts length of stay in the ICU and hospital mortality in liver transplant recipients.

Authors:  Stephanie Klinzing; Giovanna Brandi; Paul A Stehberger; Dimitri A Raptis; Markus Béchir
Journal:  BMC Anesthesiol       Date:  2014-11-15       Impact factor: 2.217

Review 3.  Methicillin-resistant Staphylococcus aureus bacteremia among liver transplant recipients: epidemiology and associated risk factors for morbidity and mortality.

Authors:  Taohua Liu; Yuezhong Zhang; Qiquan Wan
Journal:  Infect Drug Resist       Date:  2018-05-03       Impact factor: 4.003

Review 4.  Pseudomonas aeruginosa bacteremia among liver transplant recipients.

Authors:  Taohua Liu; Yuezhong Zhang; Qiquan Wan
Journal:  Infect Drug Resist       Date:  2018-11-16       Impact factor: 4.003

5.  Assessment of pathogens and risk factors associated with bloodstream infection in the year after pediatric liver transplantation.

Authors:  Yeong Eun Kim; Ho Jung Choi; Hye-Jin Lee; Hyun Ju Oh; Mi Kyoung Ahn; Seak Hee Oh; Jung-Man Namgoong; Dae Yeon Kim; Won Kyoung Jhang; Seong Jong Park; Dong-Hwan Jung; Deok Bog Moon; Gi-Won Song; Gil-Chun Park; Tae-Yong Ha; Chul-Soo Ahn; Ki-Hun Kim; Shin Hwang; Sung Gyu Lee; Kyung Mo Kim
Journal:  World J Gastroenterol       Date:  2022-03-21       Impact factor: 5.742

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.